KKR, a leading global investment firm, announced its agreement to acquire Clinisupplies from Healthium MedTech. Clinisupplies’ management team will continue to hold a minority position in the company.
KKR is investing in Clinisupplies through KKR Health Care Strategic Growth Fund II, a $4.0 billion fund focused on investing in high-growth health care companies. KKR was advised by Houlihan Lokey, Gibson, Dunn & Crutcher LLP, PWC and BCG. The financial terms of the acquisition were not disclosed.
Clinisupplies is a UK-based manufacturer and distributor of continence care products, including urinary collecting devices and catheters. Clinisupplies’ products are supplied to hospitals and pharmacies, while also available for delivery to patients directly through its home delivery services “Clinidirect.” Clinisupplies is headquartered in Watford, London and employs more than 400 employees.
Healthium Medtech is a global medtech company focused on products used in surgical, post-surgical and chronic care. One in five surgeries conducted globally uses a Healthium product.
KKR manages multiple alternative asset classes, including private equity, credit and real assets, with strategic partners that manage hedge funds. KKR has a long track record of supporting health care companies globally, having invested approximately $17 billion in the sector since 2004.
According to the LevinPro HC database, this marks the 113th Medical Devices transaction of 2022 and the 18th announced during the fourth quarter.
